用AI提升脑瘤术中荧光寿命成像的准确性与可靠性
A Data-Centric Framework for Intraoperative Fluorescence Lifetime Imaging for Glioma Surgical Guidance
- 通过置信度学习和迭代分类融合,构建高精度三类胶质母细胞瘤边界分类器
- 模型在31例患者192个组织边缘上达到96%分类准确率
- 揭示不同浸润程度的特异性光学特征,适合神经外科医生参考使用
精准评估胶质瘤浸润范围对最大化肿瘤切除同时保护功能脑组织至关重要。荧光寿命成像(FLIm)提供实时、无标记的生化对比,但其临床应用受生物异质性、类别不平衡及病理标注差异影响。本文提出一种数据驱动型人工智能(DC-AI)框架,整合置信度学习(CL)、类别精炼与目标标签评估,构建针对胶质母细胞瘤(GBM)切除边缘的多类别稳健分类器。数据来自31例新诊断的IDH野生型GBM患者,共192个组织边缘,初始由专家神经病理学家标注为7个肿瘤细胞密度等级。通过置信度学习量化点级置信度,识别标签不一致,并引导迭代合并为三类(低、中、高)。该高保真数据集训练出的模型在三分类任务中达到96%准确率。SHAP分析揭示各类别特异性FLIm特征重要性,凸显浸润谱中的独特光学信号。靶向分析进一步识别导致低置信度预测的生物学因素(如灰质成分)与采集相关因素(如血液污染)。盲法重评被CL标记的边界显示病理学家间存在变异,证明选择性重标注优于全面重审。这些发现表明,数据驱动型AI框架可系统提升数据可靠性、增强模型鲁棒性,并深化对FLIm信号的生物学解读,助力开发可临床应用的实时脑瘤边界评估光学工具。
原文摘要 · Abstract (English)
Accurate intraoperative assessment of glioma infiltration is essential for maximizing tumor resection while preserving functional brain tissue. Fluorescence lifetime imaging (FLIm) offers real-time, label-free biochemical contrast, but its clinical utility is challenged by biological heterogeneity, class imbalance, and variability in histopathological labeling. We present a data-centric AI (DC-AI) framework that integrates confident learning (CL), class refinement, and targeted label evaluation to develop a robust multi-class FLIm classifier for glioblastoma (GBM) resection margins. FLIm data were collected from 192 tissue margins across 31 newly diagnosed IDH-wildtype GBM patients and initially labeled into seven tumor cellularity classes by an expert neuropathologist. CL was applied to quantify FLIm point-level confidence, identify label inconsistencies, and guide iterative class merging into a three-class scheme ("low", "moderate", "high"). The resulting high-fidelity dataset enabled training a model that achieved 96% accuracy in the three-class task. SHAP analysis revealed class-specific FLIm feature importance, highlighting distinct optical signatures across the infiltration spectrum. Targeted FLIm analysis further identified biological (e.g., gray matter composition) and acquisition-related (e.g., blood contamination) contributors to low-confidence predictions. Blinded re-evaluation of margins flagged by CL demonstrated intra-pathologist variability, underscoring the value of selective relabeling rather than exhaustive review. Together, these findings demonstrate that a DC-AI framework can systematically improve data reliability, enhance model robustness, and refine biological interpretation of FLIm signals, supporting the development of clinically actionable optical tools for real-time glioma margin assessment.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。